Original Article Oral Lopinavir–Ritonavir for Severe Covid-19 Investigators in China report the results of an open-label, randomized clinical trial of lopinavir–ritonavir for the treatment of Covid-19 in 199 infected adult patients. The primary end point was the time to clinical improvement. Allocating Scarce Medical Resources for Covid-19 The Covid-19 […]
